Melissa Rundle

Research Fellow
Winston-Salem, United States

Advisory Committee Again Urges FDA to Vote No on Aducanumab

COMMUNITY NEWS 2021-04-14 Community News Biogen’s licensing application for aducanumab has generated controversy throughout the Alzheimer’s field, with different voices clamoring for its approval or rejection. Now, three researchers who sat on the Food and Drug Administration’s ...

PAPER Morant AV, Jagalski V, Vestergaard HT

Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016.

Clin Transl Sci. 2019 Jul;12(4):361-370. Epub 2019 Mar 2 PubMed: 30681284

PAPER Langlands G, Mackenzie J, Graham C, Watson N, Molesworth A, Summers D, Green A, Smith C, Pal S

Non-white cases of sporadic Creutzfeldt-Jakob disease: A 28 year review of United Kingdom National Surveillance Data.

J Neurol Sci. 2021 Mar 24;424:117416. PubMed: 33839436

PAPER Cao H, Han X, Jia Y, Zhang B

Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.

Aging (Albany NY). 2021 Apr 4;13 PubMed: 33839699

PAPER Oji Y, Hatano T, Funayama M, Hattori N

Reply: PSAP variants in Parkinson's disease: a large cohort study in Chinese mainland population.

Brain. 2021 Apr 12;144(3):e26. PubMed: 33844829

PAPER Yang W, Deng B, Huang Y, Liu J, Huang Z, Chang Z, Zhu S, Chan LL, Chaudhuri KR, Tan EK, Wang Q

Two heterozygous progranulin mutations in progressive supranuclear palsy.

Brain. 2021 Apr 12;144(3):e27. PubMed: 33844830

PAPER Peterson Hiller A

Response to the retraction of papers by Yoshihiro Sato- a review of vitamin D and Parkinson's disease.

Maturitas. 2021 Mar 24; PubMed: 33838971

PAPER Miyasaki JM, Lim TT, Bhidayasiri R

Editorial: Inclusion, equity, diversity and social justice in movement disorders research.

Parkinsonism Relat Disord. 2021 Mar 26; PubMed: 33840573

PAPER Siddiqi B, Koemeter-Cox A

A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson's Research and Care.

J Parkinsons Dis. 2021 Apr 2; PubMed: 33843698

PAPER Khoury R, Liu Y, Sheheryar Q, Grossberg GT

Pharmacotherapy for Frontotemporal Dementia.

CNS Drugs. 2021 Apr 11; PubMed: 33840052

PAPER Zhang JV, Irwin DJ, Blennow K, Zetterberg H, Lee EB, Shaw LM, Rascovsky K, Massimo L, McMillan CT, Chen-Plotkin A, Elman L, Lee VM, McCluskey L, Toledo JB, Weintraub D, Wolk D, Trojanowski JQ, Grossman M

Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration.

Neurol Clin Pract. 2021 Apr;11(2):105-116. PubMed: 33842063

PAPER Sen MK, Hossain MJ

Oligodendrocyte-Specific Mechanisms of Myelin Thinning: Implications for Neurodegenerative Diseases.

Front Neurosci. 2021;15:663053. Epub 2021 Mar 24 PubMed: 33841096

PAPER Steele TA, St Louis EK, Videnovic A, Auger RR

Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease.

Neurotherapeutics. 2021 Apr 12; PubMed: 33844152

PAPER Milanowski ŁM, Lindemann JA, Hoffman-Zacharska D, Soto-Beasley AI, Barcikowska M, Boczarska-Jedynak M, Deutschlander A, Kłodowska G, Dulski J, Fedoryshyn L, Friedman A, Jamrozik Z, Janik P, Karpinsky K, Koziorowski D, Krygowska-Wajs A, Jasińska-Myga B, Opala G, Potulska-Chromik A, Pulyk A, Rektorova I, Sanotsky Y, Siuda J, Sławek J, Śmiłowska K, Szczechowski L, Rudzińska-Bar M, Walton RL, Ross OA, Wszolek ZK

Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.

Parkinsonism Relat Disord. 2021 Apr 2;86:48-51. PubMed: 33845304